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Abstract 
 
Human RNase 6 is a cationic secreted protein that belongs to the RNase A 
superfamily. Its expression is induced in neutrophils and monocytes upon bacterial 
infection, suggesting a role in host defence. We present here the crystal structure of 
RNase 6 obtained at a 1.72 Å resolution, being the first report for the protein three- 
dimensional structure and thereby setting the basis for functional studies. The structure 
shows an overall kidney shaped globular fold shared with the other known family 
members. Three sulphate anions bound to RNase 6 were found, interacting to residues 
at the main active site (His15, His122 and Gln14) and cationic surface exposed 
residues (His36, His39, Arg66 and His67). Kinetic characterization, together with 
prediction of protein –nucleotide complexes by molecular dynamics, was applied to 
analyse the RNase 6 substrate nitrogenous base and phosphate selectivity. Our results 
reveal that, although RNase 6 is a moderate catalyst in comparison to the pancreatic 
RNase type, its structure includes lineage specific features that facilitate its activity 
towards polymeric nucleotide substrates. In particular, enzyme interactions at the 
substrate 5’ end can provide an endonuclease type cleavage pattern. Interestingly, the 
RNase 6 crystal structure revealed a novel secondary active site conformed by the 
His36-His39 dyad that facilitates the polynucleotide substrate catalysis. 
 
Summary statement (40 words) 
 
We describe the first human RNase 6 crystal structure in complex with sulphate anions. 
Kinetic analysis, site directed mutagenesis and molecular dynamics simulations 
identified novel substrate recognition and cleavage sites. 
 
 
Short title: RNase 6 crystal structure and substrate binding sites 
 
 
Key words: Protein crystallography, RNase k6, RNase A superfamily, sulphate anion, 
kinetic characterization, molecular dynamics. 
 
Abbreviation      list:      C>p, cytidine      2',3'-cyclic      phosphate;      EDTA, 
Ethylenediaminetetraacetic acid; GSH, reduced Glutathione; GSSG, oxidized 
Glutathione; IPTG, Isopropyl β-D-1-thiogalactopyranoside; MALDI-TOF MS, Matrix 
Assisted Laser Desorption/Ionization Mass spectrometry; MD, molecular dynamics; 
poly(C), polycytidylic acid; poly(U), polyuridylic acid; poly(A), polyadenylic acid; dsRNA, 
double stranded RNA; RMSD, root mean -square deviation; Tris, 2-Amino-2- 
hydroxymethyl-propane-1,3-diol. 
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INTRODUCTION 
 
The human RNase 6 is a protein belonging to the bovine pancreatic ribonuclease A 
(RNase A) superfamily, a vertebrate specific family comprising small secretory proteins, 
sharing a common overall three-dimensional structure and displaying a variety of 
properties. Together with the first ascribed function of pancreatic RNases to digest 
RNA, several family members were reported to be involved in innate immunity, showing 
toxicity against a wide spectrum of pathogens, from virus, bacteria, fungi and protozoa 
to helminth parasites [1][2][3]. An unusual rapid evolution rate within the family and the 
antimicrobial properties of distant related members suggested a common ancestral 
innate immunity role [4][5]. In humans, the family includes eight known members, also 
called the “canonical RNases” (Figure 1A). Despite their low sequence identity, ranging 
from 30% to 70%, we observe the conservation of the disulfide bonding pattern and the 
catalytic triad. All members are highly cationic and are localized at the long arm (q) of 
human chromosome 14 [6][7]. 
RNase 6, also named RNase k6, was first identified during a genomic search for a 
homologous protein of bovine kidney RNase (RNase k2) and localized on q11 region of 
chromosome 14 [8][9]. The newly identified human mature protein sequence was 
found to share 72% identity with its bovine RNase k2 counterpart. Divergence of the 
kidney RNases in comparison to the prototype reference family pancreatic type 
RNases supported their involvement in a differentiated biological role. Due to the 
presence of human RNase 6 in a large variety of tissues and its expression in 
monocytes and neutrophils, it was proposed that it could play a role in host defence. 
Indeed, recent studies by Becknell and collaborators showed the protein expression in 
macrophages and epithelial cells at the urinary tract in response to exposure of 
uropathogenic bacteria [10]. Spencer and co-workers also reported a potent 
antimicrobial activity in vitro against Gram negative and Gram positive bacteria for 
RNase 6, together with its closest homologue, RNase 7, and proposed both proteins as 
responsible for the mammalian urinary tract sterility maintenance [11][10]. Experimental 
evidence was also provided by the reported downregulation of RNase 6 together with 
other host innate immunity proteins induced by the human immunodeficiency virus 
(HIV) [12]. RNase 6 displays 55% amino acid identity to RNase 7, and belongs to the 
RNase 6, 7 and 8 cluster, sharing with them common structural features (Figure 1A). 
Interestingly, even though it has been found that eosinophil RNase 2 and RNase 3 
gene lineages have undergone one of the fastest rates of divergent evolution to 
produce paralogous genes [13][14], RNase 6 primate gene lineages appear to have 
evolved in a more conservative mode [9]. On the other hand, a contradictory scenario 
has been reported in rodents, in which the evolution pace of RNase 6 presents a 
substantially higher rate [15]. All in all, a similar tendency towards a isoelectric point 
increase is shared within the eosinophil lineage. 
The RNase A superfamily members share a conserved catalytic mechanism that was 
thoroughly characterized thanks to the pioneering enzymology studies during the first 
half of the XX’s century [16][17][18]. RNase A catalyzes the cleavage of the 3’5’ 
phosphodiester bond of single polynucleotide substrates, showing selectivity for 
pyrimidines at the main base subsite (B1) and a preference for purines at the secondary 
base site (B2). Degradation of polynucleotide substrate is also assisted by additional 
binding sites at both sides of the catalytic centre, referred as Bn, Rn and pn for bases, 
ribose and phosphate binding respectively [19]. 
Preliminary kinetic characterization of RNase 6 upon its discovery indicated a moderate 
catalytic efficiency respect to the family reference member RNase A. Estimation of 
kinetic parameters using yeast tRNA as a substrate reported about a 40-fold reduced 
catalytic rate in comparison to RNase 2 [8]. Further side by side comparison of RNase 
6 catalytic efficiency confirmed an overall moderate relative catalytic efficiency, higher 
than RNase 3 but significantly lower than RNase 7 [20][21][22]. 
4 
 
In this work we describe the first crystal structure of RNase 6. The protein structural 
analysis is complemented with its enzymatic characterization to highlight RNase 6 
singularity within the RNase A family context. 
 
MATERIALS AND METHODS 
 
Expression and Purification of the Recombinant Proteins 
A plasmid containing the gene of recombinant human RNase 6 was transformed in a 
prokaryote expression system. The cDNA encoding RNase 6 sequence was a kind gift 
provided by Dr. Helene Rosenberg (National Institute of Health, Bethesda, MD, USA). 
Mutant variants were constructed using the Quick Change Site-Directed Mutagenesis 
kit (Stratagene, La Jolla, CA). All constructs were confirmed by DNA sequencing and 
the purified protein was analyzed by MALDI-TOF MS and N-terminal sequencing. 
The genes were subcloned in plasmid pET11c for prokaryote high yield expression. E. 
coli BL21(DE3)-competent cells were transformed with the pET11c/RNase 6 plasmid. 
The expression protocol was optimized from the previously described procedure [20] to 
optimize RNase 6 final recovery yield. For high yield expression, bacteria were grown 
in Terrific broth (TB), containing 400 µg/mL ampicillin. Recombinant protein was 
expressed after cell induction with 1 mM IPTG added when the culture showed an A600 
=0.6. The cell pellet was collected after 4 h of culture at 37 °C. Cells were resuspended 
in 10 mM Tris-HCl, 2 mM EDTA, pH 8, and sonicated at 50 watts for 10 min with 30-s 
cycles. After centrifugation at 15,000 x g for 30 min, the pellet fraction containing 
inclusion bodies was processed as follows: the pellet fraction was washed with 50 mM 
Tris-HCl, 2 mM EDTA, 0.3 M NaCl, pH 8, and after centrifugation at 20,000 x g for 30 
min, the pellet was dissolved in 12 ml of 6 M guanidine HCl, 0.1 M Tris-acetate, 2 mM 
EDTA, pH 8.5, containing 80 mM GSH, and incubated under nitrogen for 2 h at room 
temperature. The protein was then refolded by a rapid 100-fold dilution into 0.1 M Tris- 
HCl, pH 7.5, containing 0.5 M L-arginine, and GSSG was added to obtain a 
GSH/GSSG ratio of 4. Dilution in the refolding buffer was adjusted to obtain a final 
protein concentration of 30–150 µg/mL. The protein was incubated in refolding buffer 
for 48–72 h at 4 °C. The folded protein was then concentrated, buffer exchanged 
against 0.015 M Tris-HCl, pH 7, and purified by cation exchange chromatography on a 
Resource S column equilibrated with the same buffer. The protein was eluted with a 
linear NaCl gradient from 0 to 2 M in 0.015 M Tris-HCl, pH 7 buffer. Further purification 
was achieved by a reverse phase chromatography on a Vydac C4 column, using the 
same buffers as described for the Resource S chromatography. The homogeneity of 
the purified proteins was checked by 15% SDS-PAGE and Coomassie Blue staining 
and by N-terminal sequencing. RNase 3 and RNase 7 were expressed as previously 
described [23][24]. 
 
Spectrophotometric Kinetic Analysis 
Poly(C), Poly(U), Poly(A):Poly(U), CpA, UpA, UpG and C>p (Sigma, Aldrich) were used 
as substrates, and the kinetic parameters were determined by a spectrophotometric 
method as described [20]. RNase A, used as a control protein, was purchased from 
Sigma. Assays were carried out in 50 mM sodium acetate, 1mM EDTA, pH 5.5, at  25 
ºC, using 1-cm path length cells. Substrate concentration was determined 
spectrophotometrically using the following extinction coefficients: ε268= 8400 M-1 cm-1 
for C>p; ε265= 21000 M-1 cm-1 for CpA, ε261= 23500 M-1 cm-1 for UpA, ε261= 20600  M-1 
cm-1 for UpG, ε268= 6200 M-1 cm-1 for poly(C); ε260= 9430 M-1 cm-1 for poly(U) and ε260= 
4430 M-1 cm-1 for poly(A):poly(U) for each nucleotide unit. The activity was measured 
by following the initial reaction velocities using the difference molar absorbance 
coefficients, in relation to cleaved phosphodiester bonds: ⊗ε286= 1450 M-1 cm-1 for 
CpA, ⊗ε286= 570 M-1 cm-1 for UpA, ⊗ε280= 480 M-1 cm-1 for UpG, ⊗ε250= 2380 M-1   cm-1 
for poly(C), ⊗ε282= 829 M-1 cm-1 for poly(U) and ⊗ε260= 3400 M-1 cm-1 for 
poly(A):poly(U) for 
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transphosphorylation reaction, and ⊗ε286= 1450 M-1 cm-1 for C>p hydrolysis reaction 
[20][25]. Duplicates of seven substrate concentrations (ranging from 0.1 to 2 mM) were 
tested for each condition. Final enzyme concentrations were selected from 0.1 to 10 
µM depending on the RNase activity for each assayed substrate. Kinetic parameters 
were obtained by the nonlinear regression GraFit data analysis program (Erithacus 
Software). Relative activity of RNase mutants was calculated by comparison of initial 
velocities (V0), using a substrate concentration of 0.1 mM for dinucleotides and 0.5 
mg/mL for polynucleotides. 
 
Activity staining gel 
Zymograms were performed following the method previously described [26]. 15% 
polyacrylamide-SDS gels were cast with 0.3 mg/mL of poly(C) (Sigma, Aldrich) and run 
at a constant current of 40 mA for 1.5 h. Following, the SDS was extracted from the gel 
with 10 mm Tris/HCl, pH 8, and 10% (v/v) isopropanol. The gel was then incubated in 
the activity buffer (0.1 m Tris/HCl, pH 8) to allow enzymatic digestion of the embedded 
substrate and then stained with 0.2% (w/v) toluidine blue (Merck, Darmstadt, Germany) 
in 10 mm Tris/HCl, pH 8, for 10 min. Positive bands appeared white against the blue 
background. The loading buffer had no 2-mercaptoethanol to facilitate recovery of 
active enzymes. RNase A (Sigma, Aldrich) was used as a control. 
 
Analysis of polynucleotide cleavage pattern 
The characterization of the RNases substrate cleavage pattern was carried out by 
studying the digestion product profiles, as previously described [27]. The poly(C) 
substrate (Sigma, Aldrich) was dissolved at a concentration of 0.5 mg/mL in 10 mM 
HEPES-KOH at pH 7.5. Following, 50 µl of the poly(C) solution were digested with 10 
µl of enzyme solution at 25°C during 1 h. Enzyme final concentrations were adjusted 
for each RNase: 50 nM for RNase 6 and RNase 6-H36R and 1.4 µM for RNase 6-H15A 
and RNase 7-H15A. At different digestion times the products of the reaction were 
separated by reversed-phase HPLC column (Nova Pak C18, Waters) according to the 
previously described procedure [27][28]. Briefly, the RNase- poly(C) reaction mixtures 
(50 µl and 15 µl for wild-type and mutant RNase 6 respectively) were injected into the 
column equilibrated with solvent A (10% (w/v) ammonium acetate and 1% (v/v) 
acetonitrile) and the elution was carried out by an initial 10-min wash and 50-min 
gradient from 100% solvent A to 10% solvent A plus 90% solvent B (10% (w/v) 
ammonium acetate and 11% (v/v) acetonitrile). Product elution was detected from the 
absorbance at 260 nm, and peak identification was performed according to previous 
characterization of oligocytidylic acids[29]. 
 
Protein crystallization 
RNase 6 crystals were obtained after high through screening of available commercial 
kits by the hanging drop vapour diffusion methodology at 20ºC. In one of these kits, 
JCSG-plusTM HT-96 (Molecular Dimensions), RNase 6 at 10 mg/mL was able to 
crystallize under one condition (0.2 M NaCl; 0.1 M Na cacodylate; 2 M (NH4)2SO4; pH 
6.5). This condition was optimized to improve the crystal size by the hanging drop 
methodology by mixing 1 µL of the protein sample with 1 µL of the crystallization buffer. 
The best condition resulting from this optimization was: 0.05 M NaCl, 0.1 M Na 
Cacodylate (pH 6.5) and 2 M NH4SO4. Cubic shaped crystals appeared after 10 days 
of incubation at 20 °C and were soaked in the cryoprotectant solution by adding 15 % 
glycerol to the crystallization buffer prior to X-ray exposure. 
 
Data collection, processing and protein structure solving 
Data were collected at the XALOC BL13 beamline station of ALBA synchrotron (Spain) 
using a λ = 0.9795 Å. Data collection was performed at 100ºK using a Pilatus 6M 
detector (Dectris®, Switzerland), 800 images were taken at texp = 0.2 s, ∆φ = 0.2°.The 
data obtained was processed with XDS (MPI for Medical Research, Heidelberg)  [30]. 
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Structure was solved by molecular replacement with Phenix Phaser-MR program using 
an RNase 6 model constructed upon NMR structure of RNase 7 (PDB ID:2HKY) [31]. 
Iterative cycles of refinement and manual building were applied using PHENIX [32] and 
Coot [33] respectively until no further improvement of Rfree could be achieved. Finally, 
the stereochemistry of the structure was validated with SFCHECK [34] and 
WHAT_CHECK [35]. Table 1 shows all the data collection and structure refinement 
statistics. 
 
Structure modelling 
Molecular modelling predictions were carried out using protein -nucleotide docking and 
molecular dynamics (MD) simulations. Docking simulations were conducted with 
AutoDock 4.2.6 (Scripps Research Institute. La Jolla, CA) and MD simulations were 
performed with GROMACS 4.5.5 [36]. RNase A and RNase 6 complexes with 
dinucleotides (CpA, UpA and UpG) were predicted. The initial RNase A- dinucleotides’ 
positions were determined in basis of crystallographic data of RNase A bound to 
d(CpA) [37]. For RNase 6 -dinucleotide complexes the position of the S1 sulphate was 
taken as reference. Due to the inactive position of His122 in the RNase 6 crystal, the 
position of the histidine was adjusted to the “active” conformation taking RNase A as a 
reference (PDB ID: 1RPG). 
For MD simulations the force field AMBER99SB-ILDN [38] was used both for protein 
and RNA components. All the complexes were centred in a cubic cell with a minimum 
distance box-solute of 1.0 nm. The unit cell was filled with transferable intermolecular 
potential 3P (TIP3P) water [39] in neutral conditions with 150 mM of NaCl. Neighbour 
search was performed using a group cut-off scheme with a cut-off of 1.4 nm for van der 
Waals interactions and 0.9 nm for the other short-range Lennard-Jones interactions. 
For long range interactions, smooth particle mesh of Ewald (PME) [40,41] was used 
with a fourth-order interpolation scheme and 0.16-nm grid spacing for FFT. The bonds 
were constrained with the P-LINCS algorithm [42], with an integration time step of 2 fs. 
The energy of the system was minimised using the steepest descendant algorithm and 
equilibrated in two steps. First, an initial constant volume equilibration (NVT) of 100 ps 
was performed with a temperature of 300 K using a modified Berendsen thermostat. 
Then, 100 ps of constant pressure equilibration (NPT) was run at 1 bar with a 
Parrinello-Rahman barostat [43,44] at 300 K and the same thermostat. Finally, 20 ns 
production runs were performed under an NPT ensemble without applying restraints. 
Three independent simulations in periodic boundary conditions were conducted for 
each complex. The evolution of the average RMSD for all non hydrogen ligand atoms 
after least square fitting to the original position was calculated. 
For prediction of the RNase 6-heptanucleotide complex, the RNase A- d(ATAA) crystal 
structure was taken as a reference (PDB ID:1RCN; [45]). First, the d(ATAA) 
coordinates were used to build an AUAA ribonucleotide. His122 of RNase 6 was fixed 
in the corresponding active conformation. Local search docking with 2000 cycles and 
2000 iterations was performed with AutoDock 4.2.6 [46] to adjust the AUAA position to 
RNase 6 active site. Then, three cytidines were added to the 5' end of the 
tetranucleotide. The sulphate positions of the RNase 6 structures were taken as a 
reference to place the phosphates corresponding to the extended nucleotide. 
Following, a steepest descent energy minimization of the complex was performed with 
GROMACS 4.5.5. Molecular dynamics simulations were also applied using the same 
protocol described for dinucleotides. 
 
Prediction of pKa values 
Prediction of pKa values of selected protein residues was performed using the Rosetta 
online server ROSIE [47]. The estimated pKa values of selected His residues were 
calculated by using a neighbour sphere of 15 Å and considering the protonation state 
of ionisable residues. A starting pKa reference value of 6.3 for each His was ascribed. 
The program evaluates all potential conformational rotamers together with the influence 
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of side chain and backbone mobility. RNase A (PDB ID: 7RSA) coordinates were used 
as a reference control. Predicted pKa values for His12, His105 and His119 residues in 
RNase A were found in accordance with the previously reported experimental values 
[48]. His105 in RNase A and His67 in RNase 6 were selected as control solvent 
exposed residues, not involved in Coulombic interactions with nearby residues. The 
RNase A double mutant (RNase A-H7H10) [49] crystal structure (PD ID: 5ET4; Blanco 
et al., unpublished results) was also analysed to evaluate the predicted pKa values for 
an engineered secondary site located at RNase A secondary phosphate binding site. 
 
 
RESULTS 
 
RNase 6 three-dimensional structure 
RNase 6 crystals diffracted to 1.72 Å. The structure was solved using RNase 7 
structure as a model (PDB ID: 2HKY; [31]). The crystallographic statistics for the data 
collection, processing and structure solving are provided in Table 1. Structural data for 
RNase 6 structure is available at the Protein Data Bank under the accession number 
PDB ID:4X09.The RNase 6 three-dimensional structure (Figure 1B) complies the 
RNase A superfamily overall conformation, with a kidney shaped structure formed by 7 
β-strands and 3 α-helices cross-linked by four conserved disulphide bonds, as listed in 
Table S1. Loop residues Trp1-Lys3, Gln17-Leu21, Lys63-Arg66, Gly86-Gln90 and 
Pro108-Ser112 are partially disordered. In particular, practically no electron density was 
visualised for residues Pro2, Lys3, Gln17, Leu21, Gly86 and Lys87, that could not be 
not properly modelled. Alternate side chain conformations were modelled for some 
residues (Gln14, Asn32, Ser59, His67, Met78 and Thr79). Specifically, high motion 
values were observed in loops L1, L2 and L8, where 4% of the residues are 
disordered, as reported for RNase 7 structure [31].Residues involved in crystal packing 
were analysed by the PISA web server [50]. The intermolecular contacts are listed in 
Table S2. Interactions are found mostly between β3, β4, β5 and β7 strand residues 
(Gln71, Arg82, Ala97-Tyr99, Ser125, Ile126) and loop residues. No packing contacts 
are seen in the environment of the active site, therefore enabling further substrate 
binding studies. 
An overall comparison of RNase 6 crystal structure with previously solved structures of 
RNase A superfamily members highlighted some interesting particularities. First of all, 
we observed a distinct conformation of the RNase 6 N-terminus, where Trp1, unique in 
the RNase A superfamily, folds back towards the protein core. Following, we found 
several non conserved His residues, unique for RNase 6, that contribute to the protein 
structure peculiarities. His 9 was observed to interact with Glu12 by a salt bridge, which 
would participate in the stabilization of the first alpha helix, as reported in RNase A for 
the Glu2-Arg10 salt bridge [51][52]. Unusual rotamer conformations, showing an 
unambiguous electron density, were observed for two non conserved histidines: His36 
and His 67. 
 
RNase 6 sulphate binding sites 
The protein was crystallized in the presence of ammonium sulphate and four sulphate 
anions were identified in the crystal asymmetric unit (Figures 1B and S1). Three of 
these sulphates corresponded to defined cationic regions exposed at the protein 
surface and correlate to putative RNA phosphate binding sites, while the fourth 
sulphate is involved in the crystal packing. Sulphate anion interactions with nearby 
residues are listed in Table S3 and illustrated in Figure 2. Sulphate labelled as S1 
corresponds to the active site of the enzyme, conserved in all canonical RNases. The 
presence of either a sulphate or phosphate anion at the enzyme active site was already 
reported for RNase A [53][54] and other family members: RNase 2/EDN [55], RNase 
3/ECP [56] and RNase 5/angiogenin [57]. On the other hand, the second sulphate (S2) 
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found in RNase 6 structure binds to a distinct region not reported in any other family 
members (Arg66/His67). Comparative studies of our structure with the RNase A- 
tetranucleotide analogue [45] suggested that this region may represent a distinct 
phosphate interaction subsite located at the 5’ end of the RNA substrate. Following, a 
third sulphate anion was visualized in RNase 6 structure bound to two His residues 
(His 36 and His 39), His 39 being unique for RNase 6 among all the RNase A 
members. Interestingly, both His residues together with a close by Lys (Lys87) mimic 
the disposition of a putative RNase active site (Figure 3), as also identified using the 
PDBeMotif analysis tool available at the PDBe server (http://www.ebi.ac.uk/pdbe- 
site/pdbemotif/). 
 
RNase 6 main active site 
The RNase 6 crystal structure illustrated the conservation of the active site architecture 
within the RNase A family. Residues His15, Lys38 and His122 (His12, Lys41 and 
His119 RNase A counterparts) build the active site groove, with His122 adopting the 
so-called inactive orientation [58], a conformation reported to be favoured in acidic and 
high ionic salt solutions [59]. Comparison of atomic crystal structures for RNase A 
indicated that His119 can adopt two conformations: A (active) and B (inactive), where 
the active ring orientation is required for adenine binding at the secondary base B2 site 
[37][60]. On the other hand, the active orientation of RNase A His119 ring was reported 
to be favoured by the hydrogen bond interaction with the vicinal Asp121 residue, whose 
interaction would account for the correct His119 tautomer in catalysis [61]. RNase 6 
counterpart (Asp124), located in an equivalent conformation, could also perform an 
equivalent role. However, inactive His122 conformation is fixed in our RNase 6 
structure by an hydrogen bond interaction with Lys7. Therefore, proximity of Lys7 might 
alter significantly the properties of the His122 catalytic residue. Likewise, we 
considered the potential influence of the nearby His 36/His 39 RNase 6 residues on the 
other active site His (His15). The presence of cationic residues nearby to RNase 6 
active site could shape the enzyme performance, and may account for a reduction of 
its catalytic efficiency in comparison to RNase A (Table 2, Table S4). Although RNase 6 
structure conserves equivalent positions for some key residues at the active site 
environment, as Gln14 and Asn41 (Gln11 and Asn44 respectively in RNase A), the 
proximity of residues such as Lys7, His36 or His39 should not be disregarded. 
 
RNase 6 nucleotide binding sites 
Following, RNase 6 crystal structure was further analysed to elucidate the structural 
basis for the protein substrate specificity and kinetic properties. Comparison of RNase 
6 structure with RNase A indicated conservation of most residues at the B1 site. In 
contrast, non conserved substitutions were found for Phe120 and Ser123 RNase A 
counterpart residues. Phe120 is observed in RNase A to contribute by stacking 
interactions to fix the pyrimidine ring [37]. Nevertheless, a Leu residue in RNase 6, also 
presents in RNase 3, might also contribute to shape the protein base binding 
hydrophobic cavity. In any case, the presence of Phe120 in both RNase A and RNase 
4, two very efficient RNase A family members, might also explain their relative higher 
catalytic activity. On the other hand, B1 selectivity is considered dependant on a Thr– 
Asp dyad relative position. Thr45-Asp83 interactions were attributed in RNase A to shift 
from cytidine to uridine preference [17]. However, in RNase 6 the presence of Gln 40, 
hydrogen bonded to Asp 80 (Asp83 counterpart), is fixing the later in a distinct 
orientation, that might interfere in its interaction with Thr42 (Thr45 counterpart), and 
modifies the pyrimidine binding mode. Additionally, RNase A and RNase 4 (an RNase 
with an unusual strong uridine preference [62]), have an hydrophobic residue at Gln40 
position, which was considered to help locating the Thr45 residue at the most favoured 
conformation for uridine base binding [63]. To note, Gln40-Asp80 pair is unique to 
RNase 6 among the 8 human canonical RNases (Figure 1). This scenario might 
explain in RNase 6 the observed increase Km value for both UpA and CpA respect  to 
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RNase A (Table 2). On the other hand, the orientation of Asp80, closer to RNase A 
counterpart but clearly distinct from RNase 4, may explain RNase 6 moderate 
preference for uridine at B1 site (Table 3). Interestingly, uridine predilection of RNase 4 
would be mostly determined by Arg101 residue that can directly interact with the uridine 
carbonyl group and is bringing the Asp80 closer to the Thr45 vicinity [64]. Noteworthy, 
the presence of Arg101 is characteristic of the RNase 4 lineage, whereas RNase A and 
RNase 6 have a Lys at this position which is pointing to the opposite direction. 
Next, we analysed RNase 6 structure at the secondary base site (B2). Conservation of 
Asn68 and Asn64 (Asn71 and Asn67 in RNase A respectively) is observed. 
Notwithstanding, the presence of a non conserved cationic residue at position 66 might 
alter significantly the region. Additionally, although there is a conservative substitution 
for Glu111 in RNase A (Asp107 in RNase 6), the distinct loop orientation, due to the 
presence of a Pro in RNase 6, modifies considerably the region putative interactions. 
Altogether, the B2 site architecture would provide reduced binding interactions to the 
purine base, retaining a preference for adenine versus guanine, as confirmed by our 
kinetic results (Tables 2, 3 and S4) and reported for most of the other tested 
mammalian RNase A family members [65][66][67]. Finally, we searched the RNase 6 
structure for phosphate binding sites that could contribute to the recognition of an RNA 
polymeric substrate, as described for RNase A [19]. Towards this aim, the protein 
nucleotide binding mode was further analysed by molecular modelling. 
 
Structure analysis by molecular modelling simulations 
Molecular dynamics simulations were performed to predict the overall RNase 6 
substrate binding mode. Three independent runs were carried out for a total of 20 ns. 
All ligand positions were fully stabilized after a time lapse of 5 ns, showing a final 
average RMSD ranging from 0.15 to 0.3 nm. First of all, molecular dynamics 
simulations were applied to RNase dinucleotide complexes taking as a model 
reference the RNase A-d(CpA) crystal structure[37]. Results indicated that the CpA and 
UpA dinucleotides could accommodate in a similar orientation into the RNase 6 
catalytic cleft, showing no significant displacement from the original location (Figure 4). 
A close by inspection of predicted RNase 6 -dinucleotide interactions corroborated 
some of the structural features inferred from the crystal structure analysis. Equivalent 
interactions at the phosphate position suggested a conserved binding mode at the 
main phosphate binding site (p1). Noteworthy, although the starting position of His122 
in RNase 6 crystal was found in the inactive conformation, the residue was adjusted to 
its active orientation before modelling, remaining in favoured orientation for catalysis 
after all MD simulations. Interestingly, together with equivalent relative positioning of 
Gln14, His15 and His122, the presence in the RNase 6 active site neighbourhood of 
Lys7 and Trp10 residues (Ala4 and Lys7 in RNase A) would account for significant 
differences at the p1 environment. 
The binding pattern described for RNase A was also mostly conserved for RNase 6 at 
the main pyrimidine base site (B1). Leu123 in RNase 6 was observed to partially supply 
the Phe120 stabilizing role in RNase A, but might induce a minor tilt of the ring plane. 
Interestingly, together with the conserved bidentate hydrogen bond between Thr42 and 
the pyrimidine base, the close by Gln40 could directly interact with the Asp80 and the 
N3 atom of the pyrimidine base. 
On the other hand, the comparison between the secondary base binding site (B2) of 
both RNases showed minor differences in the relative position of the adenine base, but 
a more pronounced base displacement for the guanine containing dinucleotides. 
Equivalent hydrogen bond interactions to adenine were found in RNase 6 for Asn64 
and Asn68 (Asn67 and Asn71 in RNase A), together with base stacking interactions 
with His122 (His119 in RNase A). However, although the main determinants for 
adenine binding were conserved, we observed how the presence of Arg66, unique for 
RNase 6, is significantly altering the environment. Indeed, in all our predicted protein- 
dinucleotide complexes we observed a salt bridge between Arg66 and Asp107, which 
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shifted the Asp position from the corresponding RNase A anionic residue (Glu111). 
In particular, a major displacement from the original position was observed for the UpG 
dinucleotide in complex with both RNases. Molecular dynamics simulations indicated 
that the guanine base could not properly fit into the B2 site, promoting non canonical 
orientations, where the guanine base was partially displaced. Moreover, in both 
RNases, the bidentate hydrogen bond by Asn68 (Asn71 in RNase A) was partially lost. 
Variability among replicates in the dinucleotide positioning reminded the reported 
productive and non productive binding mode for the crystallographic complexes of 
RNase A with 2’5’-UpG [68]. Additionally, interactions in both RNases between the 
guanine C2 amino group and the Asp107 (Glu111 in RNase A) residue would fix the 
base in a less favoured orientation, pushing away the phosphate from the main active 
site. Nonetheless, the relative UpG displacement from the original position was less 
pronounced in the predicted RNase A complex, probably due to the contribution of 
Phe120 stacking interactions at B1, that provide a better fixation of the pyrimidine base. 
On its side, the presence in RNase 6 of Lys7 close to the active site environment would 
favour the displacement of the phosphate towards the p2 region. 
 
Complementarily, to gain further insight into the protein nucleotide binding mode we 
modelled an -heptanucleotide complex taking the RNase A-d(ApTpApA) crystal 
structure [45] as a starting reference model (Figure 5). The oligonucleotide fitted nicely 
into the enzyme active cleft showing only significant differences from the RNase A 
binding mode at the secondary substrate binding sites. Figure 5 highlights the protein 
residues at hydrogen bond distance observed in the protein –heptanucleotide complex. 
Putative RNase 6 substrate binding sites were ascribed for base and phosphate 
recognition (Table S5). Together with conserved equivalent sites to RNase A, the 
predicted complex illustrated the presence in RNase 6 structure of unique interacting 
residues at the RNA 5’ end. A novel specific region at p
-2 and p-3 sites would be 
conformed by residues His36, His39, Lys87. Besides, stacking interactions between 
His36 and the base located at B
-2 position were also identified in the model. 
 
Kinetic characterization of RNase 6 
Next, we determined the RNase 6 enzymatic activity against a variety of RNA 
substrates to correlate the protein structure with its enzymatic properties. RNase 6 
catalytic efficiency ratio was compared with RNase 3 and RNase A (Table S4), as 
representative family members for low and high catalytic efficiency respectively 
[66][18][23]. 
First, kinetic parameters for RNase 6 were calculated for dinucleotide and cyclic 
mononucleotide substrates (Table 2). Comparison of Km and kcat values for cyclic mono 
and dinucleotides indicated that most of the decrease of the catalytic efficiency of 
RNase 6 in comparison to RNase A (from 100 to 1000 fold) is due to a reduction in the 
catalytic constant value. A side by side comparison of substrate relative ratio (Table 3) 
highlighted for RNase 6 a preference for uridine at B1 site and selectivity for adenine at 
B2. Additionally, the enzyme activity was assayed against polymeric substrates (Tables 
3 and S4). RNase 6 displayed a low catalytic efficiency for polynucleotides in 
comparison to RNase A (Figure S2), showing a similar reduced relative catalytic activity 
as previously reported for RNase 3 [20]. Interestingly, we observed that RNase 6 had 
the ability to degrade the double stranded poly(U):poly(A) substrate, a property not 
shared by RNase 3. 
Complementarily, to evaluate the contribution of RNase 6 specific subsite arrangement, 
we analysed the enzyme poly(C) cleavage pattern, as model of polymeric substrate 
(Figure 6). The oligonucleotides obtained from the substrate digestion were eluted by 
reversed-phase chromatography, where the mononucleotide fraction is eluted at the 
initial conditions and oligonucleotides of increasing size elute at increasing retention 
times. The previously optimized methodology distinguishes between consecutive sizes 
up to 8 or 9 nucleotides, whereas the peaks corresponding to higher molecular   mass 
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components contain more than one oligonucletide size due to the column 
discrimination power limitations [29]. Our previous work on RNase A cleavage pattern 
showed a decrease of the initial poly(C) peak followed by the formation of intermediate 
oligonucleotides with an average size around 6–7 residues, a pattern that supported 
the enzyme multisubsite structure providing a characteristic endonuclease type activity 
[29]. Noteworthy, RNase 6 displayed a characteristic digestion profile differentiated 
from that previously obtained for RNase A [27], where there is first the formation of 
considerably large intermediates which are subsequently digested, giving rise to 
relatively shorter intermediates. Interestingly, the decrease of the original 
polynucleotide substrate was enhanced for RNase 6 at short incubation times. On the 
other hand, the predominance of smaller oligonucleotides did not take place until most 
of the high molecular mass polymeric substrate has been degraded, revealing a 
singularized cleavage pattern, that could be ascribed to a pronounced endonuclease 
mechanism. 
 
 
Kinetic characterization of RNase 6 mutants 
Analysis of RNase 6 three dimensional structure and molecular modelling predictions 
suggested that the enzyme facility to cleave polymeric substrates could be related to 
the presence of surface exposed cationic residues that might facilitate the RNA 
anchorage and degradation. Noteworthy, the presence in RNase 6 of a His pair (His 
36/His39) (Figures 1 and S3) that adopts a configuration equivalent to the 
His15/His122 dyad at the RNase main active site, suggested the existence of a 
secondary active centre (Figure 3). To evaluate this hypothesis we designed mutant 
variants at His15 and His36. First, the enzyme main active site was removed by His15 
mutation to alanine. Residue His15 in RNase 6 was selected as RNase A His12 
counterpart, where the corresponding H12A mutant was reported by Raines and co- 
workers to totally abolish the RNase A catalytic activity [69]. Additionally, His36 was 
mutated to Arg to remove the putative secondary catalytic His while retaining an 
exposed cationic charge. Besides, most RNase A family members, including RNase 7, 
the closest RNase 6 homologue, display an Arg at an equivalent position (Figures 1 
and S3). Eventually, a double mutant (His15A/His36A) was engineered to evaluate 
simultaneously the removal of the main and secondary active sites. 
Kinetic characterization of point mutants confirmed the key role of both His15 and 
His36 (Table 4). Contribution of His36 was found mostly critical for polymeric 
substrates. On the other hand, we observed how the RNase 6 His15 to Ala mutant was 
retaining a significantly high activity for polymeric substrates (about 35-40% relative 
activity respect to wild-type RNase). Interestingly, for the assayed dinucleotides, a 
residual relative activity of about 15% was observed, which was abolished by the 
double mutation. Moreover, the RNase 6-H15A activity was further compared with the 
corresponding RNase 7-H15A mutant (Table 4). The complete abolishment of activity 
for the RNase 7 active site mutant for dinucleotides, in contrast to RNase 6-H15A, 
corroborated the hypothesis. On the other hand, a remnant activity for polynucleotides 
is observed for both the RNase 6 double mutant and RNase 7-H15A mutant. Likewise, 
residual catalytic activity for the RNase A-H12K/H119Q mutant was attributed to be 
solely promoted by the RNA structure distortion induced by the enzyme interaction[49]. 
Complementarily, the analysis of RNase 6 activity on polymeric substrates was also 
assayed on an activity staining gel and by the analysis of the polynucleotide digestion 
products. The side by side comparison of the polynucleotide cleavage product profiles 
obtained by incubation with both RNase 6-H15A and RNase 7-H15A mutants, devoid of 
the main active site His, confirmed the presence in RNase 6 of another cleavage site. 
We observed that using the same assay conditions a considerable amount of activity is 
achieved with the RNase 6-H15A mutant, while non significant activity is observed for 
the corresponding RNase 7-H15A (Figure S4). Comparison of both RNases activity on 
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poly(C) together with RNase 6 mutants was also analyzed by the zymogram technique 
(Figure S2), where the RNase 6 double mutant display no detectable activity at even a 
5 fold protein concentration. Interestingly, when comparing the poly(C) digestion 
pattern along with the His15 and 36 respective mutants’ profiles we observe how both 
mutants shifted their product elution profile towards a more exonuclease type pattern, 
accumulating shorter intermediates than the native enzyme at an earlier stage of the 
reaction. A similar profile progression was previously reported for RNase 3, described 
to present a subsites arrangement that would favor an exonuclease cleavage pattern 
[20]. 
 
 
DISCUSSION 
We report here the first crystal structure RNase 6 in complex with sulphate anions 
(Table 1). The location of putative phosphate binding sites was deduced from the 
position of the sulphate anions in the crystal structure (Figure 2 and Table S3). 
Structural analysis and kinetic characterization were carried out to outline the protein 
nucleotide binding sites arrangement. The first sulphate was ascribed to the main 
RNase phosphate binding site, shared with the other RNase A family members 
[54][55][67]. Two additional sulphate anions were located at the protein exposed 
cationic residues (His36/His39 and Arg66/His67) and would correspond to secondary 
phosphate binding sites. In particular, the His36/His39 site is proposed here as a novel 
and unique site within the RNase A family (Figures 1 and 3). Kinetic studies 
corroborated the involvement of His36 in the enzyme catalysis (Table 4). 
The contribution of RNase 6 novel secondary catalytic site in the catalytic mechanism 
was further analysed by the characterization of the enzyme polynucleotide cleavage 
pattern (Figure 6). The distribution of substrate digestion products indicated that the 
breakdown of the polymeric substrate was not a random process. The chromatography 
profiles revealed the preference of RNase 6 for the binding and cleavage of long RNA 
strands, where the broken phosphodiester bonds would be located considerably 
spaced apart from the end of the chain. By comparison with the previously 
characterized RNase A cleavage pattern [29] we concluded that the RNase 6 activity 
toward the polymeric substrate was even more endonucleolytic than the previously 
described for RNase A [19]. On the other hand, we observed how the poly(C) digestion 
profile underwent a pronounced shift in its cleavage pattern towards an exonuclease 
type propensity when the main active site His was mutated (Figure 7). 
Complementarily, structural analysis also illustrated a well defined substrate 
multisubsite arrangement for RNase 6. Interestingly, the predicted RNase 6 complex 
with an heptanucleotide by molecular dynamics (Figure 5) revealed the presence of 
novel sites at the RNA 5’ end, that would be ascribed to B
-2 and p-2/p-3 sites (Table S5). 
Interestingly, the RNase 6 structure revealed equivalent His ND1 to NE2 atomic 
distances for His15/His122 and His36/His39, suggesting the presence of a secondary 
catalytic site. Besides, we observed stacking interactions between B
-2 base of the the 
oligonucleotide and His39 in the predicted complex. However, structural analysis 
identified no additional residues for binding of adjacent bases at both phosphate sides. 
Notwithstanding, kinetic data on dinucleotides indicated a reduced efficiency 
performance for this novel active site. Indeed, the percentage of remnant catalytic 
activity displayed by the RNase 6-H15A mutant is similar to the activity displayed by a 
previously engineered RNase A construct with an additional active site created at the p2 
phosphate binding site position (RNase A-H7H10 variant) [49]. Likewise, a similar 
scenario might be envisaged for RNase 6 (see Table S6 for comparison of estimated 
pKa values for both RNase A-His7/His10 and RNase 6-His36/His39 pairs). The 
calculated pKa values for the corresponding His residues exposed at the  protein 
surface indicated that neither of them underwent a significant decrease from the 
reference value that could provide an efficient base catalyst. Therefore, the  predicted 
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pKa for His36 and His 39 could not reproduce properly the efficient RNase A catalytic 
site [48][18]. And last but not least, the presence of a third residue that could stabilize 
the transition state intermediate is not obvious. Interestingly, we find a neighbouring Lys 
residue (Lys87) at the novel site environment that could meet the required RNase 
active site geometry (see Figure 3 for a schematic illustration). Unfortunately, Lys87 
side chain is disordered in the present RNase 6 crystal structure, providing no 
information on its proper orientation. However, the Lys87 side conformation predicted 
by molecular dynamics in the RNase 6 –heptanucleotide complex did provide 
interactions to a phosphate located at the p
-3 site (Table S5). Noteworthy, Lys87 is 
found in all primate RNase 6 counterparts but is absent in the murine sequence [9][15]. 
Interestingly, even if RNase A mutant at Lys41 was shown to drastically reduce the 
enzyme catalytic efficiency [70], the insertion of a secondary catalytic site for RNase A 
at p2 location conformed by only a His dyad was also able to provide about a 10-15% 
of remnant activity in the absence of the main active site [49]. Likewise, the proposed 
novel RNase 6 secondary site would behave as a poor catalyst. In any case, the 
present kinetic data indicated that the presence of an anchoring site at the 36-39 region 
is enhancing significantly the enzyme catalysis of polymeric substrates. Interestingly, 
Sorrentino and co-workers analysis of the enzymatic properties of RNase A family 
members suggested that the presence of a cationic cluster at that region, combined 
with an anionic residue at RNase A residue at 83 position (Asp 80 in RNase 6), 
correlated to the facility to destabilize dsRNA, exposing single stranded stretches to the 
enzyme for cleavage[71][65][72]. Interestingly, RNase 6 shows a particular 
overabundance of His residues at its polypeptide sequence, in comparison to the other 
family homologues. As previously mentioned, most of these His residues are unique to 
RNase 6 lineage (Figure 1B) [9][15]. In particular, we observe two cationic clusters 
(His36/His39) and (Arg66/His67) fully conserved among the more evolved primate 
members. To note, while His36 and His67 are found in all known primate primary 
structures, His39 and Arg66 are only present in the more evolved primates. Overall, 
evolutionary pressure would have drifted RNase 6 towards a slightly more cationic 
primary structure with an overabundance of His residues, providing a novel secondary 
active site. Future research should explore the ultimate implications in the protein 
physiological function. 
 
Conclusions 
RNase 6 first crystal structure has provided us the opportunity to explore its structure - 
function relationship. By combining structural analysis together with molecular 
modelling and kinetic characterization, we were able to spot key regions contributing to 
the enzyme substrate specificity and catalytic properties. Results highlighted RNase 6 
multisubsite arrangement for substrate binding and the contribution of a secondary 
catalytic site that facilitates the cleavage of polynucleotide substrates. Further work is 
envisaged to fully characterize RNase 6 enzymatic properties towards the 
understanding of its specific mechanism of action. 
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TABLES 
 
 
 
 
Table 1: Data collection, processing and structure refinement parameters for the RNase 6 crystal 
structure (PDB ID: 4X09). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Rmerge= Σhkl Σj-1 to N|Ihkl-Ihkl(j)|/ Σhkl Σj-1 to N Ihkl(j), where N is the redundancy of the data. 
b Outermost shell is 1.78-1.72 Å. 
c Rcrystal= Σh|Fo-Fc|/ΣhFo, where Fo and Fc are the observed and calculated structure factor amplitudes of 
reflection h, respectively. 
d Rfree is equal to Rcryst for a randomly selected 5% subset of reflections not used in the refinement. 
Data collection Refinement 
Space group P212121 Resolution range (Å) Rcryst c / Rfr    d (%) 
ee 
No. of protein atoms 
No. of water molecules 
No. of bound anions 
 
R.m.s. deviation from ideality 
In bond lengths (Å) 
In bond angles (deg) 
 
Average B factors (Å2) 
All protein atoms 
Main chain atoms 
Side chain atoms 
Sulphate anion atoms 
Glycerol atoms 
Water molecules 
48.98 – 1.72 
19.28 / 22.67 
1068 
124 
4 
 
 
0.004 
0.908 
 
 
30.34 
27.30 
33.23 
57.60 
49.55 
40.67 
Unit cell 
 
a, b, c (Å) 27.73 38.86 97.97 
α, β, γ (°) 90.0 90.0 90.0 
No. of molecules in a.u. 1 
Resolution (Å) 1.72 
No. of total reflections 22981 
No. of unique reflections 11717 
Rmerge a, b (%) 2.8 (23.4) 
I/σΙ b 13.0 (2.4) 
Completess for range b (%) 99.2 (99.0) 
Wilson B factor (Å2) 24.7 
Matthews coefficient (Å3/Da) 1.80 
Solvent content (%) 31.71 
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Table 2. Kinetic parameters of RNases for dinucleotide and mononucleotide cyclic phosphate substrates. 
 
 UpA UpG CpA C>p 
Km (mM) a  2.63± 0.3 ND 1.22 ± 0.2 2.06 ± 0.3 
RNase 6 kcat (s-1) 12.9 ± 1.1 ND 1.08 ± 0.1 3.25 x10-3± 0.06 
kcat /Km (s-1 M-1) 4.90x103 ND 8.85x102 1.60 
Km (mM) 2.7 ± 0.66 ND 1.7 ± 0.3 3 ± 0.53 
RNase 3 kcat (s-1) 1.22 ± 0.12 ND 0.55 ± 0.06 3.2x10-3 ± 5.1x10-4 
kcat /Km (s-1 M-1) 4.47x102 ND 3.23x102 1.07 
Km (mM) 0.7 2.0 0.5 1.06 ± 0.1 
RNase Ab   kcat (s-1) 2.69 x103 1.38 x102 2.3 x103 2.28 ± 0.18 
kcat /Km (s-1 M-1) 3.84x106 6.9 x104 4.59x106 2.15 x103 
 
a All assays were carried out in duplicates by a spectrophometric assay as described in the 
methodology. Kinetic parameters were estimated from nonlinear regression data using the GraFit 
program. 
b Values shown for RNase A activity are taken from [73][74][75]. 
ND: Not detected at the assayed conditions. 
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Table 3. Catalytic activity ratio of RNases for the assayed nucleotides. 
 
 
CpA/UpA CpA/C>p Poly(C)/Poly(U) Poly (U)/Poly(U):Poly(A) 
RNase 6 0.18 5.5x102 1.02 0.43 
RNase 3 0.72 3.0 x102 1.74 ND 
RNase A a 1.20 2.1x103 8.14 307 
ND: Not detected at the assayed conditions. 
a Data for Poly(U):Poly(A) were taken from [76]. 
24 
 
Table 4.Relative catalytic activities for wild-type RNases 6 and 7 and mutant variants. 
 
 
UpA CpA Poly (U) Poly(U):Poly(A) 
RNase 6 100 100 100 100 
RNase 6-H15Aa 13 14 77 63 
RNase 6-H36R 94 86 36 40 
RNase 6-H15A/H36A ND ND 15 5 
RNase 7 100 100 100 100 
RNase 7-H15A ND ND 3 7 
ND: Not detected at the assayed conditions. 
aData expressed in percentage of activity in relation to the wild- 
type protein (%). Mean values were calculated from triplicate 
assays, showing in all cases a standard error below 10%. 
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FIGURE LEGENDS 
 
 
Figure 1: (A) Structure-based sequence of the eight canonical human RNases together 
with RNase A. The active sites are highlighted in yellow. The four disulphide bonds are 
labelled with green numbers. Tested mutations on RNase 6 are pointed with red 
arrows. The alignment was performed using ClustalW, and the picture was drawn using 
ESPript (http://espript.ibcp.fr/ESPript/). Labels are as follows: red box, white character 
–for strict identity; red character for similarity in a group and character with blue frame 
for similarity across groups. B) RNase 6 three-dimensional structure surface 
representation using the CONSURF web server (http://consurf.tau.ac.il/) featuring the 
relationships among the evolutionary conservation of amino acid positions within the 
RNase A family. The three-dimensional structure shows residues coloured by their 
conservation score using the colour-coding bar at the bottom image. Sulphate anions 
(S1-S4) and the glycerol (GOL) molecule found in the crystal structure are depicted. 
Conserved residues belonging to the RNase catalytic site and interacting with bound 
sulphate anions are labelled. 
 
 
Figure 2: Detail of RNase 6 interactions with sulphate bound molecules. Atoms 
involved in the protein –anion interactions are listed in Table S3. The sulphate involved 
in the crystal packing (S3) is not shown here. The picture was drawn with PyMol 1.7.2 
(DeLano Scientific). 
 
Figure 3: Illustrative scheme of the RNase 6 main active site (A) and the putative 
secondary site (B). CA atom distances are labelled together with the His ND1 to NE2 
respective distances. The figure was created with Pymol (Delano scientific). 
 
Figure 4. Predicted structure of RNase 6 and RNase A in complex with CpA, UpA and 
UpG dinucleotides after molecular dynamics simulations, as detailed in the 
methodology. Nucleotides are coloured in green. RNases interacting residues are 
coloured in magenta. Hydrogen bonds are coloured in yellow. Pictures were drawn with 
UCSF Chimera 1.10 [77]. 
 
Figure 5. RNase 6 in complex with CCCAUAA heptanucleotide after a molecular 
dynamics simulation, as described in the methodology. The heptanucleotide is coloured 
in green. The heptanucleotide is coloured in green. Interacting residues of RNase 6 are 
coloured in turquoise. Protein interacting residues and ligand atoms are coloured 
according to their element. Hydrogen bonds are coloured in yellow. Overlapped 
sulphate ions of the original coordinates of the crystal are coloured in magenta. The 
picture was drawn with UCSF Chimera 1.10. 
 
Figure 6. Poly(C) cleavage pattern obtained by RNase 6 (A) compared to RNase A[27] 
(B). Chromatography profiles of poly(C) digestion products are shown at selected 
incubation times corresponding to representative steps of the catalysis process. See 
“Materials and methods” for substrate digestion conditions. 
 
Figure 7. Poly(C) cleavage pattern by RNase 6-H15A (A) and RNase 6-H36R (B) 
mutants. Chromatography profiles of poly(C) digestion products are shown at selected 
incubation times corresponding to representative steps of the catalysis process. 
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Table S2: Intermolecular packing interactions between symmetry related molecules in 
the RNase 6 crystal. 
 
Table S3: Atomic interactions between sulphate anions, glycerol and RNase 6 
residues. 
 
Table S4. Relative catalytic activity efficiency of RNase 6 in relation to RNase A. 
 
Table S5: Proposed RNase 6 residues involved in base and phosphate substrate 
subsite. 
 
Table S6. Estimated pKa values for selected His residues in RNase 6 and RNase A 
structures. 
 
Figure S1. Electron density map for S1-S4 sulfate anions. 
 
Figure S2. Comparison of RNases activities by a zymogram assay using a poly(C) 
containing SDS-PAGE gel. 
 
Figure S3. Structural superposition of RNase 6 and other representative RNase A 
family members. 
 
Figure S4. Comparison of poly(C) cleavage patterns by RNase 6-H15A and RNase 7- 
H15A. 
 
 
 
Structure validation report for RNase 6 crystal structure (PDB ID: 4X09). 
  
 
 
Table S1: RNase 6 secondary structure elements. 
loop residues helix residues strand residues 
L1 W1 – T6 α1 K7 – H15 β1 Q40 – L44 
L2 I16 – Q22 α2 C23 – T34 β2 S59 – I60 
L3 Q35 – H39 α3 F48 – D56 β3 C69 – Q71 
L4 H45 – S47 
  
β4 V76 – S85 
L5 L57 – L58 
  
β5 R92 – K100 
L6 V61 – N68 
  
β6 F102 – D107 
L7 S72 – P75 
  
β7 V119 – I126 
L8 G86 – C91 
    
L9 P108– L118 
    
  
 
 
 
Table S2: Intermolecular packing interactions between symmetry related 
molecules in the RNase 6 crystal. Only hydrogen bond interactions are 
included, taking a cut-off of 3.4 Å as a reference, as calculated by the 
PDBePISA server [1] . 
 
symmetry 
operation 
crystal 
molecule 
interacting 
atom 
symmetry related 
molecule interacting 
atom 
 
distance 
(Å) 
 
Arg82 Nη1 Ser112 O 3.24 
 
Arg82 Nη2 Asp113 Oδ1 3.22 
 
Ile126 N Pro115 O 3.06 
x-1, y, z Lys63 Nζ Tyr116 O 2.84 
 
Lys63 Nζ Pro115 O 3.13 
 
Gln98 Oε1 Tyr116 Oη 2.43 
 
Gly86 N Met0 O 2.97 
x, y-1, z 
Gln71 Oε1 
Gln71 Nε2 
Gln35 Oε1 
Tyr88 Oη 
3.40 
2.99 
x-½, -y-½, -z Tyr99 N Ser19 Oγ 
Ser19 Oγ 
Gln49 Nε2 
2.92 
2.67 
-x, y-½, -z-½ Arg65 Nη2 Leu5 O 2.53 
 Table S3: Atomic interactions between sulphate anions, glycerol and 
RNase 6 residues. Potential hydrogen bond distances have been 
considered using a cut-off distance of 3.4 Å. 
ligand interaction 
site and atom interacting protein atom distance (Å) 
 
O1 HOH60 2.59 
  
HOH99 3.12 
  
HOH124 3.34 
 
O2 His122 Nδ1 2.66 
  
HOH42 3.02 
S1  
O3 
HOH81 
Gln14 Nε2 
2.70 
3.22 
  
His15 Nε2 3.35 
  
HOH109 2.54 
 
O4 Leu123 N 2.79 
  
His15 Nε2 2.92 
  
HOH42 3.12 
 
O1 His67 N 3.21 
  
HOH70 3.11 
  
HOH98 2.67 
  
HOH118 3.32 
S2 O2 HOH48 2.22 
  
HOH98 2.75 
 
O3 His67 N 3.20 
  
Arg66 Nε 2.64 
  
HOH98 2.62 
 
O1 Arg92 Nε 3.25 
  
Arg92 Nη2 3.05 
  
HOH82 3.02 
 
O2 Arg92 Nε 3.03 
S3  HOH35 HOH56 
3.11 
3.39 
  
HOH72 2.70 
 
O3 HOH56 3.26 
 
O4 Arg25 Nη1 2.33 
  
HOH52 3.14 
 
O1 His36 Nδ2 2.54 
  
B/HOH92 3.26 
  
HOH54 2.84 
  
Arg66 Nη2 3.39 
S4 O2 HOH107 2.70 
 
O3 His39 Nε2 3.10 
  
B/HOH92 2.20 
 
O4 A/HOH92 3.15 
  
B/HOH92 3.21 
 
O1 Ser 59 N 3.22 
  
HOH108 2.16 
GOL O2 A/Ser59 Oγ 
HOH101 
2.83 
3.05 
 
O3 HOH36 3.29 
  
Gln110 Oε1 3.16 
  
 
 
 
Table S4. Relative catalytic activity efficiency of RNase 6 in relation to RNase A. 
 
 
UpA UpG CpA C>p Poly(C) Poly(U) Poly(U):Poly(A) 
RNase A 100 100 100 100 100 100 100 
RNase 6 0.13 ND 0.02 0.07 0.41 3.25 26 
RNase 3 0.01 ND 0.007 0.05 0.48 2.29 ND 
Data are expressed in relative percentage values(%). 
ND: Not detected at the assayed concentrations. 
  
 
Table S5: Proposed RNase 6 residues involved in base and phosphate substrate 
subsite. Binding sites are labelled as defined for RNase A, where B1 and p1 are located 
at the main active site. Residues at hydrogen bond or van der Waals distances 
identified in the protein -heptanucleotide complex predicted by molecular dynamics are 
included. 
 
Protein subsite Protein residue 
 
p
-3/p-2 His36, His39, Lys87 
B
-2 His36 
p
-1 Arg82 
p0 Lys63 
B1 Thr42, Gln40 
p1 His15,Gln14, Lys38, His122 
B2 Asn64, Asn68, Arg66, His122 
  p2 Lys7, Trp10  
  
 
Table S6. Estimated pKa values for selected His residues in RNase 6 and RNase A 
structures. Values were calculated using ROSIE (http://rosie.rosettacommons.org/ [2]). 
 
 
 
Residue pKa a 
RNase 6b His15 5.3 
 
His122 6.6 
 
His36 6.5 
 
His39 6.3 
 
His67 e 6.1 
RNase Ac His12 5.8 
 
His119 6.8 
 
His105e 6.4 
RNase A-K7H/R10Hd H7 6.8 
 
H10 6.7 
 
H12 5.8 
 
H119 6.4 
 
H105 e 6.5 
 
 
a Starting reference pKa values for His side chain pKa was 6.3. 
b Values calculated using RNase 6 crystal structure (PDB ID: 4X09). 
c Values calculated using RNase A crystal structure (PDB ID: 7RSA). 
d Values for RNase A-K7H/R10H crystal structure are taken from PDB 
ID:5ET4 (Blanco et al., unpublished results). Values are the average from the 
4 protein chains at the asymmetric unit. 
e His67(RNase 6) and His105 (RNase A) were taken as reference controls as 
solvent exposed His residue not involved in Coulombic interactions with 
neighbouring residues. 
  
 
 
 
Figure legends 
 
 
Figure S1: A-D) Electron density map for S1 to S4 sulfate anions and their respective 
protein environment residues. Water molecules are depicted with red crosses. Sigma 
2Fo-Fc and FoFc electron density maps contoured at 1.5 and 3 sigma levels are shown 
(colored in dark and light blue respectively). Fo-Fc electron density map was built in the 
absence of ligands. Sulfate nomenclature corresponds to Table S3 numbering. 
 
Figure S2. Catalytic activities were determined by the zymogram technique in 15% 
SDS-PAGE containing poly(C) as a substrate. A. (Lane 1) 750 pg of RNase A. (Lane 2) 
120 ng of RNase 3. (Lane 3) 120 ng of RNase 6. (Lane 4) 120 ng of RNase 7. B. (Lane 
1) 100 ng of RNase 6. (Lane 2) 100 ng of RNase 6 H15A-H36A. (Lane 3) 250 ng of 
RNase 6 H15A-H36A. (Lane 4) 500 ng of RNase 6 H15A-H36A. (Lane 5) 100 ng of 
RNase 6 H15A. 
 
Figure S3. Structural superposition of RNase 6 and representative RNase A family 
structures (RNase A, RNase 1 and RNase 3). A) Overall structural superposition 
showing Loop L3. B) Amplification of L3 loop showing equivalent residues to His 36 
and His 39 in RNase 6. RNase 6 is coloured in green, RNase A in blue, RNase 1 in 
magenta and RNase 3 in yellow. Picture was drawn with PyMol 1.7.2 (Delano 
Scientific). 
 
Figure S4. Poly(C) cleavage patterns by RNase 6-H15A and RNase 7-H15A. Both 
chromatograms correspond to the polynucleotide digestion products obtained after 30 
min of incubation with 1.4 µM of enzyme. 
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